CNVI Conavi Medical Corp.

0.0699USD0.1000 CAD · TSXV-4.76%Mkt Cap: 9.65M USDP/E: —

Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intrava…

Institutional holders1 on file

Key Statistics

Company
Market Cap9.65M USD
Enterprise Value21.61M USD
Revenue (TTM)590.69K USD
Gross Profit5.33M USD
Net Income (TTM)-14.34M USD
Revenue/Share0.0063 USD
Last Price0.0699 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryMedical Devices
ISINCA88830X8199
Valuation
P/E (Trailing)—
P/E (Forward)-0.59
PEG—
EV/EBITDA-1.49
EV/Revenue36.59
P/S16.33
P/B-0.53
EPS (TTM)-0.17 USD
EPS (Forward)-0.12 USD
52W Range
0.06990% of range0.4544
52W High0.4544 USD
52W Low0.0699 USD
Profitability
Gross Margin83.61%
Oper. Margin-2508.99%
EBITDA Margin0.00%
Profit Margin-224.91%
ROE113.79%
ROA-164.88%
ROIC—
ROCE-350.95%
Growth
Revenue Growth106.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-17.55M USD
CapEx (TTM)127.93K USD
FCF Margin-1473.28%
FCF Yield-90.22%
Net Debt11.97M USD
Net Debt/EBITDA-0.83
Net Debt/FCF—
Balance Sheet
Debt/Equity-1.10
Current Ratio0.21
Quick Ratio0.08
Book Value/Sh-0.13 USD
Cash/Share0.0042 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.9088 USD
Upside (mean)+1200.0%
Target Range0.9088 USD – 0.9088 USD
# Analysts1
Ownership
Shares Out.137.99M
Float103.89M
Insiders32.68%
Institutions0.00%
Short Interest
Short Ratio0.3d
Short % Out.0.02%
Shares Short20.90K
Short (prev mo.)5.59K
Technical
SMA 500.0930 (-24.9%)
SMA 2000.1808 (-61.3%)
Beta-0.31
S&P 52W Chg12.00%
Avg Vol (30d)62.81K
Avg Vol (10d)38.88K
Technical Indicators
RSI (14)36.5
MACD-0.0059
MACD Signal-0.0065
MACD Hist.+0.0007
BB Upper0.0890 USD
BB Middle0.0783 USD
BB Lower0.0676 USD
BB Width27.42%
ATR (14)0.0060 USD
Vol Ratio (20d)2.16x

About Conavi Medical (CVE: CNVI)

›

Conavi Medical (CVE: CNVI) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Medical Devices industry, part of the Healthcare sector.

The shares were at 0.1000 CAD on 19 November 2026, down 84.4% over 52 weeks. Its 52-week range is 0.1000 CAD to 0.6500 CAD, and it trades at the bottom of that range.

Its market capitalisation is 13.80M CAD.

Conavi Medical reports return on equity of 113.8% and revenue up 106.3% year over year.

Its debt exceeds its cash by 17.12M CAD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. The next earnings report is expected on 31 December 2026.